ASAB - Stragenics, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue-16.289-
Cost of Revenue---
Gross Profit-16.289-
Operating Expenses
Research Development---
Selling General and Administrative61.246136.583.084
Non Recurring---
Total Operating Expenses---
Operating Income or Loss-61.246-120.291-3.084
Income from Continuing Operations
Total Other Income/Expenses Net235.72-360.957-360.957
Earnings Before Interest and Taxes174.474-481.248-3.084
Interest Expense100107.198107.198
Income Before Tax74.474-588.446-3.084
Income Tax Expense---
Minority Interest---
Net Income From Continuing Ops86.632-574.946-3.084
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income74.474-588.446-3.084
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares74.474-588.446-3.084